Jewish Healthcare Foundation Releases Report on Self-Directed Patient Safety Technology
PITTSBURGH, May 28, 2025--(BUSINESS WIRE)--The technology exists for patients and families to prevent a medication error, understand what symptoms present a potentially serious condition, avoid an emergency room or hospital visit, schedule an appointment with a local specialist of high quality—all from their phone or wearable device. In a new report released today by the Jewish Healthcare Foundation (JHF), the opportunities are clear for individuals and families to play a more active role in protecting their health through emerging technologies and digital tools.
The report, Self-Directed Patient Safety: Mapping the Emerging Landscape of Consumer-Facing Innovation, developed in partnership with TEConomy Partners, LLC, comes at a critical time: medical errors remain the third leading cause of death in the United States, healthcare spending continues to rise faster than the economy, and chronic illness affects six in ten Americans. Amid these unsustainable trends, JHF's new report identifies self-directed patient safety—the empowerment of patients to prevent harm and manage care through direct-to-consumer technologies—as a promising strategy for improving outcomes while reducing costs.
"This is a generational opportunity to rethink how we approach patient safety," said Karen Wolk Feinstein, PhD, President and CEO of the Jewish Healthcare Foundation and Pittsburgh Regional Health Initiative. "By putting modern tools directly in patients' hands—like AI-powered symptom checkers, smart medication dispensers, and remote monitoring devices—we can shift from a reactive system to one focused on prevention, engagement, and shared responsibility."
She continues, "Over a decade ago, our Foundation identified four interventions that would dramatically reduce hospitalizations: managing chronic conditions in the community, greater medication scrutiny, addressing behavioral health issues as early as possible, and engaging patients in advancing their health. The first three have gotten more attention; patient engagement remains a promising but underdeveloped opportunity."
The report explores five key areas where preventable harm often occurs—medication errors, patient care errors, diagnostic errors, infection errors, and surgical errors—and showcases timely innovations across these domains. It also outlines the market forces, regulatory barriers, and investment trends shaping the future of self-directed safety.
Key findings include:
Growing innovation and venture capital activity in consumer health tech, particularly in AI-driven health IT and digital platforms.
Notable solutions are being developed to support high-risk groups such as aging adults, new parents, individuals with chronic diseases, and rare disease patients.
Significant regulatory and economic challenges slowing adoption of direct-to-consumer safety tools—yet also opportunities for leadership in regions like Pittsburgh, which combine world-class health care with technology innovation.
The report's release supports JHF's broader mission to advance patient safety and innovation in health care. It aligns closely with recent priorities from the CMS Innovation Center, including empowering people to achieve health goals, encouraging evidence-based prevention, and leveraging technology to improve care delivery.
"As the healthcare system faces unprecedented financial and human pressures, self-directed safety is a scalable, patient-centered solution," added Dr. Feinstein. "We hope this report sparks new partnerships, policies, and products that empower people to protect themselves and their loved ones."
The full report is available at jhf.org.
Available for Interviews: Karen Wolk Feinstein, PhD, President and CEO, Jewish Healthcare Foundation
About the Jewish Healthcare Foundation
The Jewish Healthcare Foundation (JHF) and its three operating arms — the Pittsburgh Regional Health Initiative (PRHI), Health Careers Futures (HCF), and the Women's Health Activist Movement Global (WHAMglobal) — offer a unique brand of activist philanthropy to advance healthcare innovation, advocacy, collaboration, and education in the interest of better health. For more information, visit jhf.org.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250528055482/en/
Contacts
Scotland Huber, 412-594-2553huber@jhf.org
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
42 minutes ago
- Business Wire
The Open Group Launches The Open Group Open Digital Transformation™ Forum
SAN FRANCISCO--(BUSINESS WIRE)--The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. 'The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation,' commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager Digital Platforms & Architecture Design Division at Aramco. 'By developing open standards through vendor-neutral collaboration, ODXF can influence the Digital Transformation agenda towards more rigorous and successful practices.' Key focus areas for ODXF include developing standardized frameworks for Digital Transformation initiatives, ensuring consistency, and producing reference architectures which organizations can incorporate in order to make their own Digital Transformation journeys more agile and responsive. The Forum will also collaborate on establishing a body of knowledge, which incorporates a range of documents designed to help users operationalize the standard, as well as ultimately delivering a certification program for practitioners to demonstrate that they understand and can apply best-in-class approaches to Digital Transformation. 'Digital Transformation is not a new term, but the emergence of a range of disruptive technologies, from AI to quantum computing, has made it more urgent than ever for businesses to find a clear guiding path towards proven approaches to this challenge,' said Steve Nunn, President and CEO of The Open Group. 'Our track record of bringing industry stakeholders together in a neutral, collaborative space means that The Open Group is well placed to add value to one of the world's major areas of investment.' To learn more about The Open Group Open Digital Transformation Forum, please visit here. About The Open Group The Open Group is a global consortium that enables the achievement of business objectives through technology standards and open source initiatives by fostering a culture of collaboration, inclusivity, and mutual respect among our diverse group of 900+ memberships. Our Membership includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries.


Business Wire
42 minutes ago
- Business Wire
Bureau Veritas Partners with IFC's Building Resilience Index to Expand Resilience Verification Services Globally
PARIS--(BUSINESS WIRE)-- Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), has signed the first global verifier agreement to expand the reach and impact of the Building Resilience Index (BRI). Under this agreement, Bureau Veritas will serve as a verification partner for BRI across key emerging markets in Latin America, Africa, and East Asia and the Pacific. An innovation of IFC, a member of the World Bank Group, BRI is a web-based framework designed to help developers, investors, and policymakers identify risks to buildings posed by natural hazards and assess, improve, and disclose their resilience. Through this partnership with Bureau Veritas, BRI users will gain greater access to high-quality, third-party verification of climate-resilient construction practices, expanding trust and adoption of the tool in vulnerable regions where business continuity is increasingly threatened by extreme weather and related hazards. "We are delighted to become a Global Verifier of the Building Resilience Index. As climate phenomena intensify, it has become essential to integrate climate change adaptation into assets strategy. The signing of our global agreement with the International Finance Corporation marks a crucial step,' said Marc Roussel, Executive Vice President, Urbanization and Assurance at Bureau Veritas. 'Bureau Veritas has a long history as an independent third party mitigating natural and climate risks. Our network of experts will add a layer of trust so that stakeholders can rely on Building Resilience Index to evaluate vulnerability and effectiveness of adaptation strategies, worldwide.' In recent years, physical risks such as floods, cyclones, heatwaves, fires, earthquakes and landslides have posed major threats to business operations, disrupting supply chains, displacing workers and jobs, hurting productivity, and impacting insurance and financing terms. The BRI-Bureau Veritas partnership responds to a growing demand from businesses and governments for reliable tools that support risk mitigation, asset protection, and long-term economic stability. 'As businesses face increased risks to assets and infrastructure from natural disasters, the ability to assess and verify resilience is becoming a crucial element of operational and investment strategy,' said Diep Nguyen-van Houtte, Senior Manager of Climate Business at IFC. 'This partnership with Bureau Veritas strengthens the Building Resilience Index by ensuring that more clients—particularly in high-risk geographies—can benefit from credible, independently-verified insights into the resilience of their properties, adding a new tool to their climate adaptation arsenal.' By offering third-party verification through Bureau Veritas, the Building Resilience Index helps stakeholders: Protect operational continuity by identifying risks early and designing for resilience Safeguard jobs and livelihoods by minimizing disruption in vulnerable communities Enhance access to capital through better risk ratings and insurance alignment Improve public trust and accountability through independent performance validation This partnership builds on IFC's broader commitment to integrating adaptation into private sector development and enabling practical, market-driven solutions for climate resilience. BRI is funded by the Australian Government and was developed and piloted with seed funding from the Government of the Netherlands and the Rockefeller Foundation, in cooperation with leading organizations including the ARISE Private Sector Alliance for Disaster Resilient Societies, Build Change, FM Global, the Global Facility for Disaster Reduction and Recovery, Miyamoto International, and Resilience Action Fund. About Bureau Veritas: Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress. With a vision to be the preferred partner for customers' excellence and sustainability, the company innovates to help them navigate change. Created in 1828, Bureau Veritas' 84,000 employees deliver services in 140 countries. The company's technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability. Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40, CAC 40 ESG, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI. For more information, visit and follow us on LinkedIn. About IFC: IFC — a member of the World Bank Group — is the largest global development institution focused on the private sector in emerging markets. We work in more than 100 countries, using our capital, expertise, and influence to create markets and opportunities in developing countries. In fiscal year 2024, IFC committed a record $56 billion to private companies and financial institutions in developing countries, leveraging private sector solutions and mobilizing private capital to create a world free of poverty on a livable planet. For more information, visit


Business Wire
an hour ago
- Business Wire
Advicenne Receives Marketing Authorization and Reimbursement for Sibnayal® in Saudi Arabia
PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth® - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, obtains marketing authorization (MA) and reimbursement status for Sibnayal® (a fixed combination of potassium citrate and potassium bicarbonate) in the Kingdom of Saudi Arabia (KSA). Marketing authorization for Sibnayal® (ADV7103) in distal Renal Tubular Acidosis (dRTA) in KSA has been granted, based on the European registration dossier. Furthermore, Saudi authorities have agreed a reimbursement rate in line with the best European pricing. This achievment results of a close collaboration between Advicenne and its local partner, Taïba Healthcare, a leading distributor of pharmaceutical products in the Gulf region. Advicenne will act as the marketing authorization holder, while Taïba Healthcare will manage local marketing activities. The incidence of dRTA is higher in Gulf countries than in Europe or the United States, and prevalence in KSA could be estimated around 600 to 800 patients. Sibnayal® is already prescribed through early access programs in several Gulf countries outside Saudi Arabia. This milestone paves the way for registrations in GCC countries where the application is filed. Didier Laurens, CEO of Advicenne, declared: 'I am particularly proud of this important achievement and wish to congratulate both Advicenne and Taïba Healthcare teams, whose efforts were instrumental in informing and convincing the Saudi health authorities. The reimbursement obtained, comparable to the highest levels recorded in Europe, further attests to the significant therapeutic value of Sibnayal® in a region with one of the highest prevalence rates of dRTA worldwide.' About Advicenne Advicenne (Euronext: ALDVI) is a specialty pharmaceutical company founded in 2007, specializing in the development of innovative treatments in Nephrology. Its lead product Sibnayal® (ADV7103) has received its Marketing Approval for distal renal tubular acidosis in EU and GB. ADV7103 is currently in late-stage development in cystinuria in Europe and in dRTA and cystinuria in the US and in Canada. Headquartered in Paris, Advicenne, listed on the Euronext Paris stock exchange since 2017, has now been listed on Euronext Growth Paris since its transfer on March 30, 2022. For additional information, see: Disclaimer This press release contains certain forward-looking statements concerning Advicenne group and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Advicenne considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the 2024 Universal Registration Document filed with the French financial market authority on April 29, 2025 (a copy of which is available on and to the development of economic conditions, financial markets and the markets in which Advicenne operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Advicenne or not currently considered material by Advicenne. The occurrence of all or part of such risks could cause actual results, financial conditions, performance, or achievements of Advicenne to be materially different from such forward-looking statements. Advicenne expressly declines any obligation to update such forward-looking statements.